• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Diversifying the Medtronic sales force

This equity focus is basically just in favor of black people. No one cares about any other marginalized groups. Not to mention, there are so many black leaders already in the company - where exactly is the systemic racism that needs to be corrected? All these people do is self-promote themselves and their blackness, cry about low representation even though they don't seem to have any issues, and openly create racist policies and programs that only end up marginalizing non-blacks.
 




And the sad part is they run these divisions into the ground. It’s what happens when you prioritize based on race and not on merit.

More white people run businesses at MDT than black people. In fact, black people make up less than 5% of “leadership” so whose really running businesses into the ground?